International Immunopharmacology
Cure8 research brief
Limited source text
What Cure8 can confirm
What We Know
Cure8 does not have enough reliable source text to summarize this article yet. Based on the article title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. Use the original source link for the full details.
What Is Not Available
The source did not provide enough reliable article text for a source-grounded Cure8 brief. Study details, results, and limitations should be checked in the original source.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationInternational Immunopharmacology
PublisherElsevier BV
AuthorsSiyu Liu, Guijuan Cui, Tongtong Luo +5 more
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedSep 1, 2026, 12:00 AM
Content availableMetadata only
Funding disclosed by the source: Natural Science Foundation of Sichuan Province, award 2024NSFSC0054; Sichuan Provincial Administration of Traditional Chinese Medicine, award 2024ZD02; Sichuan Province Department of Science and Technology; National Natural Science Foundation of China, award U24A20790
Cure8 could not retrieve enough reliable source text to summarize this article. This page is based on the article title, source metadata, and Cure8 topic classification.
Computational toxicology prioritization of CYP3A4 and DPP7 as candidate triclosan-relevant molecular targets in ulcerative colitis
Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from Toxicology Mechanisms...
Swertiamarin promotes barrier function to alleviate ulcerative colitis by inducing autophagy via the PI3K/AKT/mTOR-signaling pathway
Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from International...
Thymoquinone–chromium–psyllium nanocomposite mitigates ulcerative colitis in association with miR-200a/NRF2 enhancement and JAK/STAT modulation
Based on the title and source metadata, this appears to be a basic science related to Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. The original article is from Journal of Drug...